Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, ...
UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...
Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease. Their ...
The researchers note that patients taking other types of HIV medications did not show the same reduction in Alzheimer's risk as those on NRTIs. Based on that, they say that NRTIs warrant clinical ...
Despite many oral, once daily, medications for treatment for adolescents with Human Immunodeficiency Virus (HIV), many ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
January 15, 2026) Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United ...
The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe. UVA Health scientists are calling for clinical trials testing the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback